Oculis Holding Ag Stock Today

OCS Stock   22.62  0.12  0.53%   

Performance

15 of 100

 
Weak
 
Strong
Good

Odds Of Distress

Less than 39

 
High
 
Low
Below Average
Oculis Holding is selling for under 22.62 as of the 21st of January 2025; that is 0.53 percent down since the beginning of the trading day. The stock's lowest day price was 22.19. Oculis Holding has about a 39 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 1st of February 2023 and ending today, the 21st of January 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
2nd of March 2023
Category
Healthcare
Classification
Health Care
Oculis Holding is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 41.95 M outstanding shares of which 41.35 K shares are now shorted by investors with about 1.26 days to cover. More on Oculis Holding AG

Moving against Oculis Stock

  0.65BIAF bioAffinity Technologies,PairCorr
  0.61UTMD Utah Medical Products Earnings Call This WeekPairCorr
  0.57VMD Viemed HealthcarePairCorr
  0.55PPERY Bank Mandiri PerseroPairCorr
  0.54BKRKY Bank RakyatPairCorr
  0.53PPERF Bank Mandiri PerseroPairCorr

Oculis Stock Highlights

ESG Sustainability
66.8%
Environmental
69.9%
Governance
71.0%
Social
CEO DirectorMD MBA
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
7 Opinions
Strong Buy71.43%Buy28.57%100%
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.00840.0089
Notably Down
Slightly volatile
Total Current Liabilities23 M22 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total1.3 M1.4 M
Notably Down
Pretty Stable
Total Assets138.1 M131.5 M
Sufficiently Up
Slightly volatile
Total Current Assets122 M116.2 M
Sufficiently Up
Slightly volatile
Oculis Holding can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Oculis Holding's financial leverage. It provides some insight into what part of Oculis Holding's total assets is financed by creditors.
100%
100%
Total Current Assets77.99%Non...8.27%Int...7.36%Other ...O...N...100%
Liquidity
Oculis Holding AG has 605 K in debt. Note however, debt could still be an excellent tool for Oculis to invest in growth at high rates of return.

Other Non Cash Items

53.06 Million
6.05.943.50.53.-1%646%15%5%100%
Oculis Holding AG (OCS) is traded on NASDAQ Exchange in USA. It is located in Bahnhofstrasse 7, Zug, Switzerland, 6300 and employs 36 people. Oculis Holding is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 953.83 M. Oculis Holding AG runs under Biotechnology sector within Health Care industry. The entity has 41.95 M outstanding shares of which 41.35 K shares are now shorted by investors with about 1.26 days to cover. Oculis Holding generates negative cash flow from operations
Check Oculis Holding Probability Of Bankruptcy
Ownership Allocation
Oculis Holding owns a total of 41.95 Million outstanding shares. Oculis Holding holds 7.23 pct. of its outstanding shares held by insiders and 26.61 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Public66.16%Institutions26.61%I...7.23%100%
Check Oculis Ownership Details

Oculis Holding Historical Income Statement

At this time, Oculis Holding's Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 1.7 M in 2025, whereas Interest Expense is likely to drop slightly above 1.1 M in 2025. View More Fundamentals

Oculis Stock Against Markets

Oculis Holding Corporate Management

Daniel JDChief OfficerProfile
Ramin MDChief OfficerProfile
Virginia DeanChief OfficerProfile
Gudrun BachmannChief OfficerProfile
Rebecca WeilChief OfficerProfile
Bastian MDChief OfficerProfile
Pll JhannessonChief OfficerProfile

Additional Tools for Oculis Stock Analysis

When running Oculis Holding's price analysis, check to measure Oculis Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oculis Holding is operating at the current time. Most of Oculis Holding's value examination focuses on studying past and present price action to predict the probability of Oculis Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oculis Holding's price. Additionally, you may evaluate how the addition of Oculis Holding to your portfolios can decrease your overall portfolio volatility.

Discover investing ideas

Utilize additional investing modules